Company / Capital Returned to Shareholders per Share
LEXICON PHARMACEUTICALS, INC. Capital Returned to Shareholders per Share History
FY2013-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.01
FY2024
5-year range
$0.01 / $0.02
FY2020-FY2024
Trend
-71.6%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Returned to Shareholders per Share has fluctuated over the past 9 years, ranging from $0.00 in FY2013 to $0.02 in FY2023.
Based on SEC 10-K filings.
0.01 in FY2024 with a 10-year CAGR of +24.5%.
Declined from $0.01 to $0.01 over the past 5 years.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -11.7%
- 10-Year CAGR
- +24.5%
Key checks
Key Insights
- In FY2024, capital returned to shareholders per share decreased 71.6% year-over-year.
- Peak capital returned to shareholders per share was recorded in FY2023.
- Lowest capital returned to shareholders per share in the period was in FY2013.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.01 | -71.6% |
| FY2023 | $0.02 | +89.1% |
| FY2019 | $0.01 | +62.4% |
| FY2018 | $0.01 | +73.5% |
| FY2017 | $0.00 | -70.3% |
| FY2016 | $0.01 | -2.4% |
| FY2015 | $0.01 | +1946.4% |
| FY2014 | $0.00 | +83.6% |
| FY2013 | $0.00 | -35.6% |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 24, 2026